News
ADVB
8.12
+4.50%
0.35
Weekly Report: what happened at ADVB last week (0803-0807)?
Weekly Report · 2d ago
Weekly Report: what happened at ADVB last week (0727-0731)?
Weekly Report · 08/03 10:18
Advanced Biomed Inc trading resumes
TipRanks · 07/30 13:40
Advanced Biomed Inc trading halted, volatility trading pause
TipRanks · 07/30 13:35
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/30 12:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 07/28 17:06
Advanced Biomed Inc trading resumes
TipRanks · 07/27 14:00
Advanced Biomed Inc trading halted, volatility trading pause
TipRanks · 07/27 13:55
Weekly Report: what happened at ADVB last week (0720-0724)?
Weekly Report · 07/27 10:23
Advanced Biomed Inc trading resumes
TipRanks · 07/24 14:45
Advanced Biomed Inc trading halted, volatility trading pause
TipRanks · 07/24 14:40
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 07/24 12:05
Biotech Stocks At 52-Week Highs - MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVB
NASDAQ · 07/24 10:29
Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focus
NASDAQ · 07/24 02:45
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 07/23 17:05
3 Penny Stocks to Watch Today, 7/23/2026
TipRanks · 07/23 15:05
Advanced Biomed Inc trading resumes
TipRanks · 07/23 14:15
Advanced Biomed Inc trading halted, volatility trading pause
TipRanks · 07/23 14:10
Biotech Stocks At 52-Week Highs - ADVB Surges +73%, BLFS Rises After Acquisition, FBRX, SLN, LBRX
NASDAQ · 07/23 08:36
Top Biotech Gainers: ZCMD Surges 190%, LABT Advances On Nu-3 Progress, ARWR Hits The Targets
NASDAQ · 07/23 03:09
More
Webull provides a variety of real-time ADVB stock news. You can receive the latest news about Advanced Biomed Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ADVB
Advanced Biomed Inc. is a holding company that operates, through its subsidiary, Advanced Biomed Inc. (Taiwan). The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.